miR‐203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver

Liver resection is still the most commonly used therapeutic treatment for hepatocellular carcinoma (HCC), and liver regeneration promotes HCC growth in the regenerating liver. The high recurrence/metastasis of HCC is the main cause of death for HCC patients after liver resection. However, how the au...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Sci
Autors principals: Zheng, Xiao‐Bo, Chen, Xiao‐Bo, Xu, Liang‐Liang, Zhang, Ming, Feng, Lei, Yi, Peng‐Sheng, Tang, Jian‐Wei, Xu, Ming‐Qing
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5378262/
https://ncbi.nlm.nih.gov/pubmed/28100026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13167
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars